| 1808667 | Testicular Safety of Filgotinib in Males with Ulcerative Colitis | 30/06/2020 |
| 1807660 | M16-006 | 29/05/2020 |
| 1807659 | M16-000 | 27/01/2023 |
| 1807651 | GS-US-419-4015 Filgotinib in treatment of Small Bowel Crohn’s Disease | 22/07/2019 |
| 1804577 | PREdiCCt | 31/05/2020 |
| 1804569 | Predictors of depression in people with Ulcerative Colitis – Version 1 | 01/11/2019 |
| 1802586 | Biomarkers of malignancy from pancreatic cysts | 03/03/2019 |
| 1802576 | MRI for early response prediction to anti-TNF therapy | 01/05/2019 |
| 1712550 | PROFILE – personalised medicine in Crohn’s disease | 28/02/2020 |
| 1711527 | GS-US-419 4016 Filgotinib in treatment of Perianal Fistulizing Crohns | 23/08/2019 |
| 1708486 | Long Term Safety of Filgotinib in Active Crohn’s Disease | 28/02/2023 |
| 1708483 | M14-234 | 01/05/2022 |
| 1708482 | M14-533 Ph 3 study in Mod/Severe Ulcerative Colitis Extension study | 30/05/2022 |
| 1707456 | Efficacy and Safety of Fligotinib in Active Crohn’s Disease | 31/12/2019 |
| 1703395 | GAST 5721 | 30/11/2020 |
| 1612343 | GAST 5634 | 31/03/2019 |
| 1609308 | GAST 5439 | 14/08/2019 |
| 1609307 | GAST 5440 | 30/06/2021 |
| 1609302 | I-CARE – IBD Cancer and Serious Infections in Europe | 31/12/2018 |
| 1607279 | SPARE | 31/03/2021 |
| 1607270 | GAST 4844 | 30/09/2021 |
| 1511175 | GAST 4684 | 13/03/2024 |
| 1511174 | GAST 4652 | 30/06/2019 |
| 1511170 | GAST 3773 | 13/03/2024 |
| 1508131 | GAST 3772 | 09/05/2021 |
| 1504079 | GAST 3559 (Ulcerative Colitis) | 28/02/2019 |
| 1307805 | PANTS | 02/06/2019 |
| 1206654 | PRED 4 – Predicting Serious Drug Side Effects in Gastroenterology | 31/12/2019 |
| 1008424 | BOSS | 14/10/2021 |
| 906278 | IBD-GEN | 10/11/2018 |
